Karpas 299

Human Non-Hodgkin's Ki-positive Large Cell Lymphoma

Cell Type:
T Cell
Tissue Origin:
blood
Species:
human
Research Area:
Cancer Research/Cell Biology
Immunotherapy / Hematology
Cell Characteristics:
Suspension

Transfection Information

Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol Kit Program Cells Efficiency Viable Cells Substrate Format Platform
V A-030 5e6 56% 62% Plasmid (general) 2 µg 100 µl I/II/2b
V

D-023

2e6 47.2% 60.7% Plasmid (general) 1 µg 100 µl I/II/2b
V

D-023

2e6 68.9% 64.8% Plasmid (general) 1 µg 100 µl I/II/2b

Citations

Categories:
Transfection 
Authors:
Hirsch B, Hummel M, Bentink S, Fouladi F, Spang R, Zollinger R, Stein H, Dürkop H 
In:
Am J Pathol (2008) 172(2): 510-20 
Categories:
Transfection 
Authors:
Staber PB, Vesely P, Haq N, Ott RG, Funato K, Bambach I, Fuchs C, Schauer S, Linkesch W, Hrzenjak A, Dirks WG, Sexl V, Bergler H, Kadin ME, Sternberg DW, Kenner L, Hoefler G 
In:
Blood (2007) 110(9): 3374-83 
Categories:
Transfection 
Authors:
Yang C, Jo SH, Csernus B, Hyjek E, Liu Y, Chadburn A, Wang YL 
In:
Am J Pathol (2007) 170(2): 722-32 
Categories:
Transfection 
Authors:
Krysov SV, Rowley TF, Al-Shamkhani A 
In:
Mol Cancer Ther (2007) 6(2): 703-11 
Categories:
Transfection 
Authors:
Honorat JF, Ragab A, Lamant L, Delsol G, Ragab-Thomas J 
In:
Blood (2006) 107(10): 4130-8